5.14x ROAS Selling Peptides on Meta in the USA
Peptide brands on Meta face a constraint most operators don't fully grasp until it's too late: the product cannot be advertised for human use.
Peptide brands on Meta face a constraint most operators don’t fully grasp until it’s too late: the product cannot be advertised for human use. That single classification shapes the entire funnel, creatives, copy, lander, architecture, and the penalty for getting it wrong isn’t a rejected ad. It’s account bans, MATCH listing, and regulatory exposure.
We built a compliant system that held the legal line and still performed. Eight-point-zero-one times return on the best-performing campaign. Seventy purchases. Fifty dollars and eighty-nine cents blended cost per purchase.
CLIENT CONTEXT
The client operates a peptide brand in the US, selling through e-commerce in a legally ambiguous niche. The product is classified as not for human use, a designation that immediately disqualifies most standard advertising approaches on Meta and puts the brand under heightened scrutiny from both the platform and regulators.
THE PROBLEM
The “not for human use” classification isn’t just a label. It’s a constraint that shapes every layer of the campaign.
Creatives can’t show or imply human consumption. Copy can’t reference dosage, results, or benefits in the way that actually sells the product. Landing pages have to hold the same compliance line or the entire account gets flagged. One misstep and the consequences go beyond ad rejection, account bans, MATCH listing, and potential regulatory exposure are all on the table.
Most brands in this space either don’t attempt Meta at all or accept creatives so diluted they can’t convert. The ads stay live but nothing sells. The alternative, pushing the line, works until it doesn’t, and when it doesn’t, the damage is permanent.
The client had seen this play out. Previous approaches had failed. The niche was perceived as too difficult for paid acquisition. Internal expertise to navigate the compliance and performance balance didn’t exist. They needed a partner who understood where the lines are, and how to perform within them.
ZP’S APPROACH
What the client needed wasn’t better creative. It was a system where compliance and performance were solved as the same problem, not traded off against each other.
Every piece of copy, every visual, every landing page element was built around what the classification allows from the start, not adapted after the first rejection. Creative was designed to sell without crossing into human-use territory. The product positioning stayed within the legal boundaries while maintaining enough commercial directness to actually convert.
The result was a system that never fought the review process because it was never built against it.
PERFORMANCE DASHBOARD
RESULTS
Best Campaign ROAS: 8.01x
Blended ROAS (All Campaigns): 5.14x
Total Purchases: 70
Blended Cost Per Purchase: $50.89
Total Spend: $3,562.46
Total Conversion Value: $19,826
Campaign Period: May 8th 2026- June 26th 2026
No account bans. No MATCH listing. No regulatory issues. In a niche where most brands can’t keep ads live for a week, this system ran across the maximum campaign window without a single compliance failure.
CLIENT REACTION
The client came in with a clear constraint and a clear ask, keep the system alive and make it perform. When the results started landing, the response on Slack said everything.
“This ROAS is amazing. Can we scale even harder?”
An unprompted request to top up budget mid-campaign isn’t a courtesy. It’s a signal. When a client in one of Meta’s most restricted categories is asking to scale harder, the system is working.
THE TAKEAWAY
Restricted doesn’t mean unrunnable. It means you need an operator who knows where the lines are.
Peptides on Meta sit in one of the most legally constrained categories in e-commerce advertising. Most brands accept that the platform is off-limits or settle for creatives so watered down they don’t convert. Neither has to be the answer.
For this client, the breakthrough wasn’t a single ad or a lucky campaign. It was building a system that treated compliance as the foundation, and performance as the outcome. Eight-point-zero-one times ROAS on the best campaign. Five-point-one-four times blended across the account. Seventy purchases. Zero compliance incidents.
The constraint didn’t kill the campaign. It shaped how we built it.
📩 1-tap message us:
Disclaimer: These results reflect individual case studies, not guaranteed outcomes. Performance depends on multiple variables including strategy, spend, funnel quality, and niche dynamics.